Results of a sub-study of DELIVER called MTN-042B was published on March 31 in PLOS ONE.

Results of a sub-study of DELIVER called MTN-042B was published on March 31 in PLOS ONE.  A detailed examination of more than 10,000 medical records at maternity clinics and hospitals in Malawi, South Africa, Uganda and Zimbabwe, MTN-042B yielded important insights about pregnancy and neonatal outcomes in these communities as well as the frequency with which different complications occur.  The data are invaluable to the DELIVER study of the dapivirine vaginal ring and Truvada as PrEP in pregnant people, and a huge step forward in providing safe and effective biomedical HIV prevention options for use during pregnancy.